- Home
- KRMD vs JZXN Comparison
KRMD vs JZXN Comparison
Compare KRMD & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- JZXN
- Stock Information
- Founded
- KRMD 1980
- JZXN 2019
- Country
- KRMD United States
- JZXN China
- Employees
- KRMD N/A
- JZXN N/A
- Industry
- KRMD Medical/Dental Instruments
- JZXN Retail-Auto Dealers and Gas Stations
- Sector
- KRMD Health Care
- JZXN Consumer Discretionary
- Exchange
- KRMD Nasdaq
- JZXN Nasdaq
- Market Cap
- KRMD 126.9M
- JZXN N/A
- IPO Year
- KRMD N/A
- JZXN 2021
- Fundamental
- Price
- KRMD $3.15
- JZXN $2.33
- Analyst Decision
- KRMD Strong Buy
- JZXN
- Analyst Count
- KRMD 4
- JZXN 0
- Target Price
- KRMD $4.63
- JZXN N/A
- AVG Volume (30 Days)
- KRMD 113.3K
- JZXN 330.0K
- Earning Date
- KRMD 05-07-2025
- JZXN 05-19-2025
- Dividend Yield
- KRMD N/A
- JZXN N/A
- EPS Growth
- KRMD N/A
- JZXN N/A
- EPS
- KRMD N/A
- JZXN N/A
- Revenue
- KRMD $35,083,740.00
- JZXN $1,400,139.00
- Revenue This Year
- KRMD $16.50
- JZXN N/A
- Revenue Next Year
- KRMD $15.47
- JZXN N/A
- P/E Ratio
- KRMD N/A
- JZXN N/A
- Revenue Growth
- KRMD 19.65
- JZXN N/A
- 52 Week Low
- KRMD $1.86
- JZXN $1.00
- 52 Week High
- KRMD $5.05
- JZXN $7.82
- Technical
- Relative Strength Index (RSI)
- KRMD 64.92
- JZXN 38.81
- Support Level
- KRMD $2.51
- JZXN $2.01
- Resistance Level
- KRMD $3.35
- JZXN $2.30
- Average True Range (ATR)
- KRMD 0.19
- JZXN 0.79
- MACD
- KRMD 0.09
- JZXN -0.19
- Stochastic Oscillator
- KRMD 81.31
- JZXN 12.58
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).